Search Results - "Chabot, G"

Refine Results
  1. 1

    Liposomal encapsulation of the natural flavonoid fisetin improves bioavailability and antitumor efficacy by Seguin, Johanne, Brullé, Laura, Boyer, Renaud, Lu, Yen Mei, Ramos Romano, Miriam, Touil, Yasmine S., Scherman, Daniel, Bessodes, Michel, Mignet, Nathalie, Chabot, Guy G.

    Published in International journal of pharmaceutics (28-02-2013)
    “…Liposomal formulation of fisetin improves its bioavailability (A) and antitumor efficacy in mice (B). Lewis lung carcinoma bearing mice treated with empty…”
    Get full text
    Journal Article
  2. 2

    Synthesis and in vitro evaluation of potential anticancer activity of mono- and bis-1,2,3-triazole derivatives of bis-alkynes by Elamari, Hichem, Slimi, Riadh, Chabot, Guy G., Quentin, Lionel, Scherman, Daniel, Girard, Christian

    Published in European journal of medicinal chemistry (01-02-2013)
    “…In order to find new molecules with cytotoxic activity against cancer cells, we prepared bis-akyne amides derived from propiolic acid. The bis-alkynes were…”
    Get full text
    Journal Article
  3. 3

    Fisetin disposition and metabolism in mice: Identification of geraldol as an active metabolite by Touil, Yasmine S., Auzeil, Nicolas, Boulinguez, François, Saighi, Hanane, Regazzetti, Anne, Scherman, Daniel, Chabot, Guy G.

    Published in Biochemical pharmacology (01-12-2011)
    “…Although the natural flavonoid fisetin (3,3′,4′,7-tetrahydroxyflavone) has been recently identified as an anticancer agent with antiangiogenic properties in…”
    Get full text
    Journal Article
  4. 4

    Activation of Retinoic Acid Receptor-dependent Transcription by All-trans-retinoic Acid Metabolites and Isomers by Idres, Nadia, Marill, Julie, Flexor, Maria A, Chabot, Guy G

    Published in The Journal of biological chemistry (30-08-2002)
    “…We have shown that four metabolites of all- trans -retinoic acid (ATRA) (4-oxo-, 4-OH-, 18-OH-, and 5,6-epoxy-RA) can induce maturation of NB4 promyelocytic…”
    Get full text
    Journal Article
  5. 5

    Bioavailability of polyphenol liposomes: a challenge ahead by Mignet, Nathalie, Seguin, Johanne, Chabot, Guy G

    Published in Pharmaceutics (17-09-2013)
    “…Dietary polyphenols, including flavonoids, have long been recognized as a source of important molecules involved in the prevention of several diseases,…”
    Get full text
    Journal Article
  6. 6

    Clinical pharmacokinetics of irinotecan by CHABOT, G. G

    Published in Clinical pharmacokinetics (01-10-1997)
    “…This article reviews the clinical pharmacokinetics of a water-soluble analogue of camptothecin, irinotecan [CPT-11 or…”
    Get full text
    Journal Article
  7. 7

    Identification of human cytochrome P450s involved in the formation of all-trans-retinoic acid principal metabolites by Marill, J, Cresteil, T, Lanotte, M, Chabot, G G

    Published in Molecular pharmacology (01-12-2000)
    “…Cytochrome P450 (P450)-dependent metabolism of all-trans-retinoic acid (atRA) is important for the expression of its biological activity. Because the human…”
    Get more information
    Journal Article
  8. 8
  9. 9

    Possible involvement of programmed cell death pathways in the neuroprotective action of polyphenols by Bastianetto, S, Krantic, S, Chabot, J-G, Quirion, R

    Published in Current Alzheimer research (01-08-2011)
    “…One of the hallmarks of Alzheimer's disease is the accumulation of senile plaques composed of extra-cellular aggregates of beta-amyloid (Aβ) peptides. It is…”
    Get more information
    Journal Article
  10. 10

    Short- and Long-Term Outcome of Patients with Pseudo-Vitamin D Deficiency Rickets Treated with Calcitriol by Edouard, T, Alos, N, Chabot, G, Roughley, P, Glorieux, F. H, Rauch, F

    “…Background: Pseudo-vitamin D deficiency rickets (PDDR; OMIM 264700) is a rare autosomal recessive disorder caused by mutations in the CYP27B1 gene, leading to…”
    Get full text
    Journal Article
  11. 11

    Cyclic Administration of Pamidronate in Children with Severe Osteogenesis Imperfecta by Glorieux, Francis H, Bishop, Nicholas J, Plotkin, Horacio, Chabot, Gilles, Lanoue, Ginette, Travers, Rose

    Published in The New England journal of medicine (01-10-1998)
    “…Osteogenesis imperfecta, often referred to as “brittle-bone disease,” is a heritable disorder characterized in most affected persons by either a reduction in…”
    Get full text
    Journal Article
  12. 12

    Irinotecan (CPT-11) high-dose escalation using intensive high-dose loperamide to control diarrhea by Abigerges, D, Armand, J P, Chabot, G G, Da Costa, L, Fadel, E, Cote, C, Hérait, P, Gandia, D

    “…Diarrhea is a serious side effect that may prevent the administration of high doses of the antitumor drug Irinotecan (CPT-11). Intensive, high-dose loperamide…”
    Get more information
    Journal Article
  13. 13

    Synthesis of cytotoxic ferrocenyl flavones via a ferricenium-mediated 1,6-oxidative cyclization by Monserrat, Jean-Philippe, Chabot, Guy G, Hamon, Louis, Quentin, Lionel, Scherman, Daniel, Jaouen, Gérard, Hillard, Elizabeth A

    “…The oxidation of the ferrocenyl group of 2'-hydroxyferrocenyl chalcones activates the beta-position of the unsaturated ketone to nucleophilic attack to yield…”
    Get more information
    Journal Article
  14. 14
  15. 15

    Phase I and pharmacologic studies of the camptothecin analog irinotecan administered every 3 weeks in cancer patients by Abigerges, D, Chabot, G G, Armand, J P, Hérait, P, Gouyette, A, Gandia, D

    Published in Journal of clinical oncology (01-01-1995)
    “…A phase I study was undertaken to determine the maximum-tolerated dose (MTD), principal toxicities, and pharmacokinetics of the novel topoisomerase I inhibitor…”
    Get more information
    Journal Article
  16. 16
  17. 17

    Importance of dose-schedule of 5-aza-2'-deoxycytidine for epigenetic therapy of cancer by Lemaire, Maryse, Chabot, Guy G, Raynal, Noël Jm, Momparler, Louise F, Hurtubise, Annie, Bernstein, Mark L, Momparler, Richard L

    Published in BMC cancer (02-05-2008)
    “…The inactivation of tumor suppressor genes (TSGs) by aberrant DNA methylation plays an important role in the development of malignancy. Since this epigenetic…”
    Get full text
    Journal Article
  18. 18

    Localization and modulation of calcitonin gene-related peptide-receptor component protein-immunoreactive cells in the rat central and peripheral nervous systems by Ma, W, Chabot, J.-G, Powell, K.J, Jhamandas, K, Dickerson, I.M, Quirion, R

    Published in Neuroscience (01-01-2003)
    “…Calcitonin gene-related peptide (CGRP) is widely distributed in the central and peripheral nervous system. Its highly diverse biological activities are…”
    Get full text
    Journal Article
  19. 19

    In Vivo Electrochemical Detection of Nitric Oxide in Tumor-Bearing Mice by Griveau, Sophie, Dumézy, Charlotte, Séguin, Johanne, Chabot, Guy G, Scherman, Daniel, Bedioui, Fethi

    Published in Analytical chemistry (Washington) (01-02-2007)
    “…Interest in elucidating the mechanisms of action of various classes of anticancer agents and exploring the pathways of the induced-nitric oxide (NO) release…”
    Get full text
    Journal Article
  20. 20

    Retinoic acid metabolism and mechanism of action: a review by Marill, Julie, Idres, Nadia, Capron, Claude C, Nguyen, Eric, Chabot, Guy G

    Published in Current drug metabolism (01-02-2003)
    “…Retinoids are vitamin A (retinol) derivatives essential for normal embryo development and epithelial differentiation. These compounds are also involved in…”
    Get more information
    Journal Article